Mechanistically, T3 acts to alter the BA composition by targeting CYP8B1, a sterol 12-hydroxylase required for CA synthesis, and then the subsequently altered BA profiles, particularly the increased non-12-OH FXR-antagonistic BAs, potentiates the GLP-1 production and insulin secretion by repressing FXR signaling
however, there are heterogeneous results regarding the changes that may occur in PCR and MDA levels
Complete prior authorization carefully incomplete forms are the top cause of first denials
"Zepbound (tirzepatide) Label Information." Garvey WT, et al
GLP-1 receptor agonists mimic a hormone in your body that: Regulates appetite and reduces hunger
The liver breaks down alcohol, but the process can generate harmful substances that damage liver cells and promote inflammation